We have located links that may give you full text access.
Histopathological study of pseudophakic bullous keratopathy developing after anterior chamber of iris-supported intraocular lens implantation.
Sixty corneal buttons excised from patients who developed pseudophakic bullous keratopathy after anterior chamber or iris-supported intraocular lens implantation were studied morphologically and statistically. The mean age of patients was 72.5 +/- 11.6 years. The mean interval between intraocular lens implantation and keratoplasty was 5.1 +/- 2.2 years. Degeneration and conversion of endothelial cells, abnormal proliferation of posterior collagenous layer, and edema of stroma and epithelium were noticed morphologically. Twenty-nine of the 60 specimens showed a surviving endothelial cell area of less than 50%. In these specimens a significant increase in the thickness of the central stroma was recognized compared with the other 31 specimens. The number of keratocytes in the 29 specimens had decreased significantly compared with the control. A linear regression study showed a significant relationship between the thickness of the stroma and the number of keratocytes. The keratocyte density decreased predominantly in the posterior part of the stroma.
Full text links
Related Resources
Trending Papers
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection.International Journal of Molecular Sciences 2024 April 4
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
A Guide to the Use of Vasopressors and Inotropes for Patients in Shock.Journal of Intensive Care Medicine 2024 April 14
Diagnosis and Management of Cardiac Sarcoidosis: A Scientific Statement From the American Heart Association.Circulation 2024 April 19
Essential thrombocythaemia: A contemporary approach with new drugs on the horizon.British Journal of Haematology 2024 April 9
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app